1. Home
  2. VERU vs NEOV Comparison

VERU vs NEOV Comparison

Compare VERU & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • NEOV
  • Stock Information
  • Founded
  • VERU 1971
  • NEOV 2018
  • Country
  • VERU United States
  • NEOV United States
  • Employees
  • VERU N/A
  • NEOV N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • NEOV Industrial Machinery/Components
  • Sector
  • VERU Health Care
  • NEOV Miscellaneous
  • Exchange
  • VERU Nasdaq
  • NEOV Nasdaq
  • Market Cap
  • VERU 85.5M
  • NEOV 72.2M
  • IPO Year
  • VERU 1990
  • NEOV N/A
  • Fundamental
  • Price
  • VERU $0.49
  • NEOV $5.06
  • Analyst Decision
  • VERU Strong Buy
  • NEOV Strong Buy
  • Analyst Count
  • VERU 2
  • NEOV 1
  • Target Price
  • VERU $4.00
  • NEOV $7.50
  • AVG Volume (30 Days)
  • VERU 1.4M
  • NEOV 310.9K
  • Earning Date
  • VERU 08-07-2025
  • NEOV 05-09-2025
  • Dividend Yield
  • VERU N/A
  • NEOV N/A
  • EPS Growth
  • VERU N/A
  • NEOV N/A
  • EPS
  • VERU N/A
  • NEOV N/A
  • Revenue
  • VERU $16,886,419.00
  • NEOV $4,255,136.00
  • Revenue This Year
  • VERU N/A
  • NEOV $208.50
  • Revenue Next Year
  • VERU N/A
  • NEOV $128.75
  • P/E Ratio
  • VERU N/A
  • NEOV N/A
  • Revenue Growth
  • VERU 134.43
  • NEOV 52.64
  • 52 Week Low
  • VERU $0.45
  • NEOV $1.80
  • 52 Week High
  • VERU $1.42
  • NEOV $6.11
  • Technical
  • Relative Strength Index (RSI)
  • VERU 34.85
  • NEOV 67.60
  • Support Level
  • VERU $0.57
  • NEOV $4.71
  • Resistance Level
  • VERU $0.61
  • NEOV $5.69
  • Average True Range (ATR)
  • VERU 0.04
  • NEOV 0.57
  • MACD
  • VERU -0.01
  • NEOV 0.03
  • Stochastic Oscillator
  • VERU 0.13
  • NEOV 62.43

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About NEOV NeoVolta Inc.

NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.

Share on Social Networks: